Withangulatin A是一种COX-2抑制剂，通过抑制MAPK、NF-κB和Akt/mTOR/p70S6K通路，发挥抗肿瘤、抗炎及杀锥虫活性。

[1] Liu Q, Chen J, Wang X, Yu L, Hu LH, Shen X. Withagulatin A inhibits hepatic stellate cell viability and procollagen I production through Akt and Smad signaling pathways. Acta Pharmacol Sin. 2010 Aug;31(8):944-52. doi: 10.1038/aps.2010.72. Epub 2010 Jul 19. PMID: 20644552; PMCID: PMC4007817.[2]Sun L, Liu J, Cui D, Li J, Yu Y, Ma L, Hu L. Anti-inflammatory function of Withangulatin A by targeted inhibiting COX-2 expression via MAPK and NF-kappaB pathways. J Cell Biochem. 2010 Feb 15;109(3):532-41. doi: 10.1002/jcb.22430. PMID: 19950196.